Our response to the UKHSA’s latest HIV data
Last Updated:We comment on the UKHSA's latest HIV data.
We comment on the UKHSA's latest HIV data.
Cabotegravir (CAB-LA) will help close the prevention gap for people who face barriers to adhering to oral PrEP.
Our calls for the new HIV Action Plan for England
We are deeply disappointed by the decision not to recommend CAB-LA as an HIV prevention option.